NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that it is scheduled to present at the Goldman Sachs 29th Annual Global Healthcare Conference in Dana Point, CA on Thursday, June 12, 2008 at 10:00 a.m. PDT. A corporate overview will be provided, including additional information on ImClone’s product portfolio.
